LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today ...
STAAR Surgical (STAA) is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon’s laser vision ...
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...
This past month marked an important transition for our company as we stepped into the roles of Interim co-Chief Executive Officers. We are honored by the Board’s confidence and deeply grateful for the ...
On Tuesday, Staar Surgical Company (NASDAQ:STAA) reported a fourth-quarter 2024 EPS loss of 69 cents, a turnaround from an income of 16 cents, missing the consensus loss of 16 cents. The contact lens ...
Shares of Staar Surgical Co. dropped 25% on Feb. 11 after it surprised Wall Street when it reported fourth quarter sales falling 36% to $49 million. Two weeks later, the Lake Forest-based maker of ...
Please provide your email address to receive an email when new articles are posted on . The acquisition is expected to close in 6 to 12 months. The transaction will include STAAR’s family of EVO ICLs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results